Filing Details

Accession Number:
0001104659-22-118549
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-14 16:12:56
Reporting Period:
2022-11-11
Accepted Time:
2022-11-14 16:12:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1745020 Theseus Pharmaceuticals Inc. THRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242992 P Timothy Clackson C/O Theseus Pharmaceuticals, Inc.
314 Main Street
Cambridge MA 02142
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-11 2,500 $6.80 351,030 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported is a weighted average price of shares purchased. These shares were purchased in multiple transaction at prices ranging from $6.595 to $6.807, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.